Skip to main content

Table 4 Antibiotics resistance among the major isolates

From: Bacteriological profile and antibiotic susceptibility of neonatal sepsis in neonatal intensive care unit of a tertiary hospital in Nepal

Antibiotic

Klebsiella (N = 23)

CONS (14)

Enterobacter (N = 13)

Acinetobacter (N = 8)

Escherichia coli (N = 3)

Serratia rubidaea (N = 3)

R/(R + S)

R %

R/(R + S)

R %

R/(R + S)

R %

R/(R + S)

R %

R/(R + S)

R %

R/(R + S)

R %

Beta-lactam Antibiotics

 Oxacillin

6/6

100

8/10

80

3/3

100

2/2

100

1/1

100

1/2

50

 Cefotaxime

19/21

90.5

4/6

66.7

10/12

83.4

6/7

85.7

3/3

100

1/3

33.3

 Meropenem

0/18

0

4/5

80

2/10

20

4/7

57.1

2/3

66.7

0/3

0

 Pip-Taz

4/10

40

1/2

50

2/4

50

3/6

50

2/2

100

1/3

33.3

Non-beta-lactam Antibiotics

 Amikacin

12/21

57

5/10

50

0/1

0

7/7

100

3/3

100

1/3

33.3

 Gentamicin

15/20

75

7/12

58.3

5/13

38.5

5/7

71.4

2/3

66.7

1/3

33.3

 Chloramphenicol

13/20

65

5/11

45.5

8/13

61.5

7/7

100

3/3

100

3/3

100

 Ciprofloxacin

16/21

76.2

8/10

80

5/13

38.5

3/16

18.8

3/3

100

1/3

33.3

 Ofloxacin

13/18

72.2

8/12

66.7

1/12

8.3

4/6

66.7

3/3

100

1/3

33.3

 Linezolid

–

–

0/3

0

–

–

1/1

100

–

–

0/1

0

 Vancomycin

1/1

100

0/4

0

1/1

100

–

–

–

–

0/1

0

 Tigecycline

2/11

18.2

–

–

1/7

14.3

2/6

33.3

0/2

0

0/1

0

 Colistin

2/18

11.2

–

–

1/8

12.5

1/5

20

0/3

0

1/3

33.3

  1. CONS Coagulase negative staphylococi, Pip-Taz Piperacillin-Tazobactam, R Number of resistant isolates, R% Percentage of resistant isolates, S Number of susceptible isolates, [−] Not tested